{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:29:32Z","timestamp":1792682972229,"version":"4.5.0"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Heart J Cardiovasc Pharmacother"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1093\/ehjcvp\/pvv051","type":"journal-article","created":{"date-parts":[[2015,12,10]],"date-time":"2015-12-10T04:04:14Z","timestamp":1449720254000},"page":"266-272","source":"Crossref","is-referenced-by-count":53,"title":["The role of trimetazidine in cardiovascular disease: beyond an anti-anginal agent"],"prefix":"10.1093","volume":"2","author":[{"given":"Cian P.","family":"McCarthy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kieran V.","family":"Mullins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Kerins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,12,9]]},"reference":[{"key":"2016090608422782000_2.4.266.1","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1742-1241.1968.tb04953.x","article-title":"Trimetazidine in the treatment of angina pectoris","volume":"22","author":"Brodbin","year":"1968","journal-title":"Br J Clin Pract"},{"key":"2016090608422782000_2.4.266.2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht296"},{"key":"2016090608422782000_2.4.266.3","doi-asserted-by":"publisher","DOI":"10.1006\/jmcc.2002.2060"},{"key":"2016090608422782000_2.4.266.4","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.86.5.580"},{"key":"2016090608422782000_2.4.266.5","doi-asserted-by":"publisher","DOI":"10.1517\/14728210903544482"},{"key":"2016090608422782000_2.4.266.6","unstructured":"Banach M . The role of trimetazidne in the treatment of heart diseases. Poznan: Termedia Publishing House; 2006."},{"key":"2016090608422782000_2.4.266.7","doi-asserted-by":"publisher","DOI":"10.1006\/jmcc.1994.1116"},{"key":"2016090608422782000_2.4.266.8","first-page":"90","article-title":"Effects of trimetazidine on the calcium transport and oxidative phosphorylation of isolated rat heart mitochondria","volume":"92","author":"Guarnieri","year":"1997","journal-title":"Basic Res Cardiol"},{"key":"2016090608422782000_2.4.266.9","first-page":"3735","article-title":"Trimetazidine protects against hypoxia-reperfusion-induced cardiomyocyte apoptosis by increasing microRNA-21 expression","volume":"8","author":"Yang","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"2016090608422782000_2.4.266.10","first-page":"517","article-title":"The role of trimetazidine in inhibiting cardiomyocyte apoptosis","volume":"3","author":"Ruixing","year":"2007","journal-title":"Arch Med Sci"},{"key":"2016090608422782000_2.4.266.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(96)00112-5"},{"key":"2016090608422782000_2.4.266.12","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvq181"},{"key":"2016090608422782000_2.4.266.13","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000086964.07404.A5"},{"key":"2016090608422782000_2.4.266.14","first-page":"1775","article-title":"Effectiveness of trimetazidine in stable effort angina due to chronic coronary insufficiency. A double-blind versus placebo study","volume":"15","author":"Passeron","year":"1986","journal-title":"Presse Med"},{"key":"2016090608422782000_2.4.266.15","doi-asserted-by":"publisher","DOI":"10.2143\/AC.59.6.2005248"},{"key":"2016090608422782000_2.4.266.16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1994.tb04276.x"},{"key":"2016090608422782000_2.4.266.17","doi-asserted-by":"publisher","DOI":"10.1097\/00045391-200501000-00006"},{"key":"2016090608422782000_2.4.266.18","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.2001.2896"},{"key":"2016090608422782000_2.4.266.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2012.11.001"},{"key":"2016090608422782000_2.4.266.20","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.78.4.353"},{"key":"2016090608422782000_2.4.266.21","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5273(02)00367-4"},{"key":"2016090608422782000_2.4.266.22","first-page":"CD003614","article-title":"Trimetazidine for stable angina","volume":"4","author":"Ciapponi","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"2016090608422782000_2.4.266.23","doi-asserted-by":"publisher","DOI":"10.1159\/000332369"},{"key":"2016090608422782000_2.4.266.24","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.22.2941"},{"key":"2016090608422782000_2.4.266.25","first-page":"68","article-title":"Myocardial necrosis induced by temporary occlusion of a coronary artery in the dog","volume":"70","author":"Jennings","year":"1960","journal-title":"Arch Pathol"},{"key":"2016090608422782000_2.4.266.26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra071667"},{"key":"2016090608422782000_2.4.266.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2005.09.012"},{"key":"2016090608422782000_2.4.266.28","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.105.100834"},{"key":"2016090608422782000_2.4.266.29","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(95)90063-2"},{"key":"2016090608422782000_2.4.266.30","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-004-0505-4"},{"key":"2016090608422782000_2.4.266.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2006.11.004"},{"key":"2016090608422782000_2.4.266.32","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2006.107524"},{"key":"2016090608422782000_2.4.266.33","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5273(00)00443-5"},{"key":"2016090608422782000_2.4.266.34","doi-asserted-by":"publisher","DOI":"10.2165\/00129784-200707020-00006"},{"key":"2016090608422782000_2.4.266.35","doi-asserted-by":"publisher","DOI":"10.1159\/000375289"},{"key":"2016090608422782000_2.4.266.36","doi-asserted-by":"publisher","DOI":"10.1080\/02841850801995413"},{"key":"2016090608422782000_2.4.266.37","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2006.097477"},{"key":"2016090608422782000_2.4.266.38","first-page":"292","article-title":"Trimetazidine in the prevention of contrast induced nephropathy after coronary angiogram","volume":"21","author":"Rahman","year":"2012","journal-title":"Mymensingh Med J"},{"key":"2016090608422782000_2.4.266.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2014.04.052"},{"key":"2016090608422782000_2.4.266.40","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1177\/1074248415573320","article-title":"Trimetazidine decreases risk of contrast-induced nephropathy in patients with chronic kidney disease: a meta-analysis of randomized controlled trials","volume":"6","author":"Nadkarni","year":"2015","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"2016090608422782000_2.4.266.41","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-12-8-1233"},{"key":"2016090608422782000_2.4.266.42","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/oxfordjournals.eurheartj.a059685","article-title":"Therapeutic value of a cardioprotective agent in patients with severe ischaemic cardiomyopathy","volume":"11","author":"Brottier","year":"1990","journal-title":"Eur Heart J"},{"key":"2016090608422782000_2.4.266.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.03.060"},{"key":"2016090608422782000_2.4.266.44","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2010.208751"},{"key":"2016090608422782000_2.4.266.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2012.09.123"},{"key":"2016090608422782000_2.4.266.46","first-page":"49","article-title":"Antiischemic efficacy of trimetazidine in patients with intermittent claudication and effort angina","volume":"43","author":"Syrkin","year":"2003","journal-title":"Kardiologiia"},{"key":"2016090608422782000_2.4.266.47","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2011.01.003"},{"key":"2016090608422782000_2.4.266.48","doi-asserted-by":"publisher","DOI":"10.2515\/therapie:2005061"},{"key":"2016090608422782000_2.4.266.49","unstructured":"European Medicines Agency\u2014Science Medicines Health. European Medicines Agency recommends restricting use of trimetazidine-containing medicines. Press release. European Medicines Agency 2012;EMA\/CHMP\/417861\/2012."}],"container-title":["European Heart Journal - Cardiovascular Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ehjcvp\/article-pdf\/2\/4\/266\/6721744\/pvv051.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T03:27:38Z","timestamp":1692156458000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcvp\/article-lookup\/doi\/10.1093\/ehjcvp\/pvv051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,9]]},"references-count":49,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,9,6]]},"published-print":{"date-parts":[[2016,10]]}},"alternative-id":["10.1093\/ehjcvp\/pvv051"],"URL":"https:\/\/doi.org\/10.1093\/ehjcvp\/pvv051","relation":{},"ISSN":["2055-6837","2055-6845"],"issn-type":[{"value":"2055-6837","type":"print"},{"value":"2055-6845","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,9]]}}}